APA

Tsimberidou A. M., Fu S., Ng C., Lim J. A., Wen S., Hong D., Wheler J., Bedikian A. Y., Eng C., Wallace M., Camacho L. H. & Kurzrock R. (20101012). A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. : Cancer.

Chicago

Tsimberidou Apostolia M, Fu Siqing, Ng Chaan, Lim Jo Ann, Wen Sijin, Hong David, Wheler Jennifer, Bedikian Agop Y, Eng Cathy, Wallace Michael, Camacho Luis H and Kurzrock Razelle. 20101012. A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. : Cancer.

Harvard

Tsimberidou A. M., Fu S., Ng C., Lim J. A., Wen S., Hong D., Wheler J., Bedikian A. Y., Eng C., Wallace M., Camacho L. H. and Kurzrock R. (20101012). A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. : Cancer.

MLA

Tsimberidou Apostolia M, Fu Siqing, Ng Chaan, Lim Jo Ann, Wen Sijin, Hong David, Wheler Jennifer, Bedikian Agop Y, Eng Cathy, Wallace Michael, Camacho Luis H and Kurzrock Razelle. A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. : Cancer. 20101012.